Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Quality of Recovery after Thyroid Surgery
NCT05016518Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Sep 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in thyroid neoplasm (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Quality of Recovery-15. Started Sep 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on NCT05016518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016518.